http://rdf.ncbi.nlm.nih.gov/pubchem/patent/KR-20130017525-A
Outgoing Links
| Predicate | Object |
|---|---|
| assignee | http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_687dca2ff72bed2d916196f8c958c482 |
| classificationCPCAdditional | http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C12Q2600-158 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C12Q2600-118 |
| classificationCPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/G01N33-574 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C12Q1-6886 |
| classificationIPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/G01N33-574 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C12N15-11 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C12Q1-68 |
| filingDate | 2011-08-11-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| inventor | http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_ac800db004fcc6554f56e615ac2c707e http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_1ce2a230881702dcacafc2ecc6c1cd6f http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_cbb7fd777e61bb827b28d8b5ff7817b5 |
| publicationDate | 2013-02-20-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber | KR-20130017525-A |
| titleOfInvention | Biomarker and its use for early diagnosis of colorectal cancer, breast cancer, kidney cancer or thyroid cancer |
| abstract | The present invention is a composition for diagnosing colorectal cancer, breast cancer, kidney cancer or thyroid cancer comprising an agent for measuring the expression level of the mRNA of APOC1 (Apolipoprotein C1) gene or protein thereof, colon cancer, breast cancer, kidney cancer or thyroid cancer comprising the composition A diagnostic kit, a method for detecting a colorectal cancer, breast cancer, kidney cancer or thyroid cancer marker APOC1 comprising measuring the expression level of the APOC1 gene or the protein encoded by the gene from a sample of a suspected cancer and colon cancer , A method for diagnosing breast cancer, kidney cancer or thyroid cancer, a method of screening for a colorectal cancer, breast cancer, kidney cancer or thyroid cancer therapeutic agent that measures the expression level of the APOC1 gene or protein after administration of a substance that is expected to treat cancer, and suspected cancer The level of APOC1 gene or protein was measured from the patient's sample. For higher than breast cancer, colon cancer, kidney cancer, prostate cancer or benign diagnosis of thyroid cancer, and liver cancer, lung cancer or ovarian cancer is related to a method for predicting that voice. |
| isCitedBy | http://rdf.ncbi.nlm.nih.gov/pubchem/patent/EP-3169814-B1 http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-2023191543-A1 http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-2016011068-A1 http://rdf.ncbi.nlm.nih.gov/pubchem/patent/KR-20210124772-A http://rdf.ncbi.nlm.nih.gov/pubchem/patent/KR-101431062-B1 http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-11639527-B2 |
| priorityDate | 2011-08-11-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type | http://data.epo.org/linked-data/def/patent/Publication |
Incoming Links
Total number of triples: 144.